Application for the Reassessment of a Hazardous Substance under ...

More documents

Recommendations

Info

Table VI: Occupational Exposure Estimates & Risk AssessmentScenarios (17-19): Enclosed Space Fogging Applications with RTU GasOperation / RPE / PPEApplicationRate(g a.i./m 3 )VolumeTreated(m 3 )Dermalabsorbed dose(mg/day) aInhalationabsorbed dose(mg/day) aTotal operatorsystemic exposure(mg/kg b.w./day) aRiskQuotient(RQ) bScenario 17 & 18: Enclosed space fogging using RTU gas cylinders with automatic/remote application (exposure only at cylinder connection/disconnection)One 7L cylinder: Mixing/loading: gloves cMixing/loading: Half-face respirator + glovesTwo 7L cylinders: Mixing/loading: Half-face respirator + gloves cMixing/loading: Full-face RPE + glovesScenario 19: Enclosed space fogging using RTU gas cylinders with manual applicationMixing/loading: Half-face respirator + gloves cApplication: No PPE0.05 375, 3750 0.0420.0420.05 12,500 0.0840.05 375(1.5 minexposure,one 7Lcylinder)Mixing/loading: Half-face respirator + gloves c0.05 3750Application: Full-face RPE + chem. resistant full-body + boots +(15 mingloves dexposure,one 7LApplication: Air-hose RPE + chem. resistant full-body + boots +gloves d cylinder)Mixing/loading: Full-face respirator + gloves c0.05 12,500gloves d exposure;Application: Full-face RPE + chem. resistant full-body + boots +(50 min0.0840.0420.01670.0420.00910.00910.0840.03020.120.0120.0240.00480.0120.00890.0120.125nil0.00480.4167)0.00230.00080.00150.00131.70.61.10.9) 0.0011 0.8)) 0.0027or 0.0001)1.90.1) 0.0077 6Dichlorvos reassessment – application Page 298 of 436
Application: Air-hose RPE + chem. resistant full-body + boots +gloves dabctwo 7Lcylinders)Assumes 30% dermal absorption for concentrate and for diluted spray; 100% inhalation absorption; 70kg body weight at application;0.0302 nil or 0.0017 1.2RQ = Total Estimated Occupational Exposure (dermal mixing/loading & application, plus inhalation at mixing/loading & application per kg body weight) / AOEL whereAOEL = 0.0014 mg/kg b.w./day; RQ > 1 indicates the likelihood of an unacceptable risk to those exposed;APVMA assumptions (2008): dermal exposure, 0.001 mL/cylinder change (equivalent to 0.0014g dichlorvos, and with 30% dermal absorption, a systemic dose of 0.00042g;glove penetration, 10%); inhalation exposure, 0.12 mg/cylinder change;dP for PPE (% penetration): none, 1 (100%); overalls, 0.2 (20%); chemical resistant full-body suit, 0.05 (5%); gloves, 0.1 (10%);P for RPE (% penetration): none, 1 (100%); half-face respirator, 0.1 (10%); full-face, 0.02 (2%); air-hose/SCBA, nil exposure (0%) (Thongsinthusak et al., 1993 in APVMA,2008b).Dichlorvos reassessment – application Page 299 of 436
Page 1 and 2:
Application for the Reassessment of
Page 3 and 4:
6.1 Evaluation of options to streng
Page 5 and 6:
EXECUTIVE SUMMARYIn briefERMA New Z
Page 7 and 8:
Aerosol containing 50 g/kgdichlorvo
Page 9 and 10:
ERMA New Zealand‘s recommendation
Page 11 and 12:
26 - 29Outdoor public space usage30
Page 13 and 14:
Substance details1-8,11-16,20-25,30
Page 15 and 16:
1.2.3 In 2008, the Environmental Ri
Page 17 and 18:
Table 1. Dichlorvos-containing subs
Page 19 and 20:
public environments and use for bio
Page 21 and 22:
available to it. In preparing this
Page 23 and 24:
3.3 International regulatory positi
Page 25 and 26:
3.6 Classification3.6.1 The HSNO cl
Page 27 and 28:
Hazard Class /SubclassClassificatio
Page 29 and 30:
Hazard Class /SubclassClassificatio
Page 31 and 32:
Rates:Fogging: 13 ml / litre (water
Page 33 and 34:
BV2 SurfaceInsecticideBV2 SurfaceIn
Page 35 and 36:
Table 7.Dichlorvos outdoor and indo
Page 37 and 38:
Scenario Crop/Use Method Rate Appli
Page 39 and 40:
humidity conditions. The higher res
Page 41 and 42:
4.3 EnvironmentIdentification of ad
Page 43 and 44:
4.3.9.3 Aquatic environment - Groun
Page 45 and 46:
is considered to be highly improbab
Page 47 and 48:
RiskGroupRQ range Level of risk Use
Page 49 and 50:
RiskGroupRQ range Level of risk Use
Page 51 and 52:
assessment, as the Use Scenario inc
Page 53 and 54:
Nonnegligible1 < RQ < 10Nonnegligib
Page 55 and 56:
Table 12.LifecycleStageImport,manuf
Page 57 and 58:
LifecycleStageUse -bystanderUseScen
Page 59 and 60:
Table 13.Identification of benefici
Page 61 and 62:
value that can be attributed to dic
Page 63 and 64:
outbreak, MAF‘s ability to demons
Page 65 and 66:
the duty of the Crown is not merely
Page 67 and 68:
5.1.7.1 J. Hicking stated that dich
Page 70 and 71:
Table 14. Comparative of hazard cla
Page 72 and 73:
Crop Pest Active ingredient Preharv
Page 74 and 75:
Crop Pest Active ingredient Preharv
Page 76 and 77:
SECTION 6- PROPOSALS TO MANAGE RISK
Page 78 and 79:
Assessment was carried out with spe
Page 80 and 81:
6.1.11 Controls to protect bystande
Page 82 and 83:
Table 16Effect of additional contro
Page 84 and 85:
Use Scenario Receptor Level of Risk
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
have, and notes the following as ar
Page 108 and 109:
Table 18Summary of benefits associa
Page 110 and 111:
UseScenariosAssessment ofEffectOutc
Page 112 and 113:
Substance detailsHSR000126DDVPInsec
Page 114 and 115:
Table 22.there are no practicable r
Page 116:
7.4 Preliminary Recommendations7.4.
Page 119 and 120:
method and LOQ)Water (principle ofm
Page 121 and 122:
Appendix B: Environmental Fate of d
Page 123 and 124:
Bioconcentration factor Gnathopogon
Page 125 and 126:
Table C.2:Scenarios used in exposur
Page 127 and 128:
Scenario 3: Vegetables - 1 applicat
Page 129 and 130:
FIELD AND STANDARD POND HALFLIFE VA
Page 131 and 132:
insectivorous bird7 Passionfruit Sm
Page 133 and 134:
4 Leafyvegetables(BBCH ≥50)4 Leaf
Page 135 and 136:
summer)7 passionfruit(BBCH 10-19)7
Page 137 and 138:
Ground (lowboom)0.03 0.03 1.07 1.07
Page 139 and 140:
Appendix D: Ecotoxicity of dichlorv
Page 141 and 142:
ioaccumulationClearance timeLevel o
Page 143 and 144:
Table D.5:Toxicity to terrestrial i
Page 145 and 146:
Appendix E: Risk Assessment: Enviro
Page 147 and 148:
Aquatic organsimsTable E.3:Environm
Page 149 and 150:
12345Crop type Table I.1 (Annex 1)
Page 151 and 152:
7 passionfruit(BBCH 20-39)7 passion
Page 153 and 154:
Fruit (tree) 2052 70759 >50Passionf
Page 155 and 156:
Appendix F: Human Toxicity of dichl
Page 157 and 158:
CONTENTS:Title Page 11 Purpose 2Con
Page 159 and 160:
2 SUBSTANCE IDENTIFICATIONIUPAC nam
Page 161 and 162:
However, dichlorvos has genotoxic p
Page 163 and 164:
4 ABSORPTION, DISTRIBUTION, METABOL
Page 165 and 166:
aerosol cans (230-330 g dichlorvos)
Page 167 and 168:
4.3 Metabolism:found in tissues of
Page 169 and 170:
dose of 1.0 mg/kg bw, a single gava
Page 171 and 172:
eports. LD 50 = 46.4 mg/kg b.w. is
Page 173 and 174:
6 ACUTE DERMAL 6.1HSNO Classificati
Page 175 and 176:
7 ACUTE INHALATION 6.1HSNO Classifi
Page 177 and 178:
measured and it was not possible to
Page 179 and 180:
8 SKIN IRRITATION 6.3 & CORROSION 8
Page 181 and 182:
9 EYE IRRITATION 6.4 & CORROSION 8.
Page 183 and 184:
10 RESPIRATORY SENSITISATION 6.5AHS
Page 185 and 186:
Justification for Classification: U
Page 187 and 188:
12 MUTAGENICITY 6.6HSNO Classificat
Page 189 and 190:
ERMA New Zealand CONFIDENTIAL Repor
Page 191 and 192:
The ATSDR (1997) reported:“Dichlo
Page 193 and 194:
•ATSDR (1997): http://www.atsdr.c
Page 195 and 196:
13 CARCINOGENICITY 6.7HSNO Classifi
Page 197 and 198:
fibroadenomas were observed in 6 (1
Page 199 and 200:
• Sex/Numbers:• Test material:
Page 201 and 202:
The NTP Peer Review concluded that:
Page 203 and 204:
concurrent studies for comparison w
Page 205 and 206:
The APVMA (2008a) reported a chroni
Page 207 and 208:
was exposed. The estimated daily in
Page 209 and 210:
14 REPRODUCTIVE TOXICITY 6.8HSNO Cl
Page 211 and 212:
ppm during premating days, signific
Page 213 and 214:
Toxicology, Chemistry and Life Scie
Page 215 and 216:
addition, there was an increase in
Page 217 and 218:
• Maternal toxicity NOAEL =• Ma
Page 219 and 220:
Research Triangle Park, North Carol
Page 221 and 222:
16 REPRODUCTIVE OR DEVELOPMENTAL TO
Page 223 and 224:
17 SPECIFIC TARGET ORGAN TOXICITY 6
Page 225 and 226:
There was a significant dose-relate
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
KEY STUDY:• Type of study:• Spe
Page 235 and 236:
BACKGROUND:The APVMA (2008a) also r
Page 237 and 238:
cholinesterases can only be estimat
Page 239 and 240:
Page 241 and 242:
Ltd, Sittingbourne Research Center,
Page 243 and 244:
23 OTHER POTENTIAL TOXIC ENDPOINTS2
Page 245 and 246:
―Results“Mortalities and clinic
Page 247 and 248: 1984). QA study. Study conducted ac
Page 249 and 250: “No information was located on im
Page 251 and 252: “Comment: These incidents clearly
Page 253 and 254: 25 ACCEPTABLE OPERATOR EXPOSURE LEV
Page 255 and 256: to pretreatment activity). When the
Page 257 and 258: cholinesterase inhibition in health
Page 259 and 260: protect agricultural workers who ha
Page 261 and 262: Wash: refers to skin washes; Dressi
Page 263 and 264: Hazard Class/SubclassHazardclassifi
Page 265 and 266: Hazard Class/SubclassHazardclassifi
Page 267 and 268: REFERENCES:APVMA, 2008a. ―DICHLOR
Page 269 and 270: Appendix 1:APVMA - Summary of bench
Page 271 and 272: “Inhalational NOEL for Occupation
Page 273 and 274: activity). In fact, treatment was s
Page 275 and 276: LAST PAGEDichlorvos reassessment -
Page 277 and 278: Dichlorvos:Occupational, Bystander,
Page 279 and 280: CONTENTS:Title Page 11 Purpose 2Con
Page 281 and 282: 3ACTIVITY SCENARIOS3.1 Table (I) su
Page 283 and 284: access of bystanders to treated are
Page 285 and 286: can reduce dermal exposures to mixe
Page 287 and 288: contaminated with, respectively 0.0
Page 289 and 290: The modelling is based upon dischar
Page 291 and 292: Table II: Occupational Exposure Est
Page 293 and 294: Table III: Occupational Exposure Es
Page 295 and 296: Operation / RPE / PPETable IV: Occu
Page 297: 1.25L product/ha; work rate, 1.25 h
Page 301 and 302: Application: Half-face RPE + overal
Page 303 and 304: P for RPE (% penetration): none, 1
Page 305 and 306: Table X: Occupational Exposure Esti
Page 307 and 308: provided: work day exposure is limi
Page 309 and 310: 5POST-APPLICATION OR RE-ENTRY WORKE
Page 311 and 312: D = DFR x TC x DA x WR x AR x P / B
Page 313 and 314: Re-entry into out-door crops (Scena
Page 315 and 316: Re-entry into treated glasshouses d
Page 317 and 318: acceptable 240 minutes after applic
Page 319 and 320: Re-entry into treated glasshouses u
Page 321 and 322: Table XVII: Re-entry into glasshous
Page 323 and 324: lowest use rate (52 mg/m 3 ; 1300g
Page 325 and 326: DA = percentage dermal absorption [
Page 327 and 328: Re-entry into treated enclosed indu
Page 329 and 330: nature of the building itself, not
Page 331 and 332: Conclusions on re-entry worker expo
Page 333 and 334: 6BYSTANDER & RESIDENT EXPOSURE & RI
Page 335 and 336: Children’s incidental ingestion o
Page 337 and 338: Table XX: Spray driftExposure throu
Page 339 and 340: Exposure through contactwithcontami
Page 341 and 342: Conclusions on bystander and reside
Page 343 and 344: Table XXIII: Dichlorvos Use Scenari
Page 345 and 346: mixing/loading. Mixing/loading fogg
Page 347 and 348: 7.23 Re-entry for ventilation of in
Page 349 and 350:
REFERENCES:APVMA, 2008a. ―DICHLOR
Page 351 and 352:
Appendix 1:Occupational Exposure Es
Page 353 and 354:
FactorExposure (μg/kg a.i. handled
Page 355 and 356:
Inhalation exposure from cylinder c
Page 357 and 358:
[0.01875 x {(0.018 x 0.05) + (2.68
Page 359 and 360:
With half-face respirator (protecti
Page 361 and 362:
With full-body chemical resistant c
Page 363 and 364:
Appendix 4:Occupational Exposure Es
Page 365 and 366:
With overalls and gloves (protectio
Page 367 and 368:
The Dermal Exposure (D) is 2.06 μg
Page 369 and 370:
TTR = turf transferable residues -
Page 371 and 372:
F = fraction of residue retained on
Page 373 and 374:
TTR = transferable residues - the E
Page 375 and 376:
Public Space ApplicationsScenario (
Page 377 and 378:
ERMA New Zealand‟s comment on the
Page 379 and 380:
Enclosed SpaceAgricultural UseOutdo
Page 381 and 382:
Appendix H: Qualitative Descriptors
Page 383 and 384:
1.3. The likelihood applies to the
Page 385 and 386:
Appendix I: Data from which classif
Page 387 and 388:
Endpoint Units * Dichlorvos Propoxu
Page 389 and 390:
Toxicity mixture calculationsSubcla
Page 391 and 392:
Subclass 9.3 -Ecotoxicity to terres
Page 393 and 394:
Table J.1:Existing controls for dic
Page 395 and 396:
TrackingcontrolsIdentification cont
Page 397 and 398:
Table J.2:Summary of default contro
Page 399 and 400:
Hazardous Substances (Classes 1 to
Page 401 and 402:
Hazardous Substances (Classes 6, 8,
Page 403 and 404:
Hazardous Substances (Classes 6, 8,
Page 405 and 406:
(a) means piping that—(i) is conn
Page 407 and 408:
Code I29 Regs 51, 52 Signage requir
Page 409 and 410:
Non-HSNO Act controlsAgricultural C
Page 411 and 412:
Appendix K: Overseas regulatory act
Page 413 and 414:
Product Use Further details ofuseSu
Page 415 and 416:
Risk assessment identified concerns
Page 417 and 418:
Current usesFormulations:Methods of
Page 419 and 420:
CanadaStatusPMRA are undertaking a
Page 421 and 422:
Appendix L: Parties consulted durin
Page 423 and 424:
Animal Products Act 19995. The purp
Page 425 and 426:
14. Regulatory control of these pro
Page 427 and 428:
Zealand‘s trade in primary produc
Page 429 and 430:
processed and stored. It employs ve
Page 431 and 432:
may be taken to risk management in
Page 433 and 434:
Appendix A• Agricultural Compound
Page 435 and 436:
Appendix O: ReferencesACVM (2010) h
show all

Application for the Reassessment of a Hazardous Substance under ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?